Cargando…

Mesenchymal stem cells for restoration of ovarian function

With the progress of regenerative medicine, mesenchymal stem cells (MSCs) have received attention as a way to restore ovarian function. It has been reported that MSCs derived from bone marrow, adipose, umbilical cord blood, menstrual blood, and amniotic fluid improved ovarian function. In light of p...

Descripción completa

Detalles Bibliográficos
Autor principal: Yoon, Sook Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Reproductive Medicine 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436469/
https://www.ncbi.nlm.nih.gov/pubmed/30827071
http://dx.doi.org/10.5653/cerm.2019.46.1.1
_version_ 1783406820777263104
author Yoon, Sook Young
author_facet Yoon, Sook Young
author_sort Yoon, Sook Young
collection PubMed
description With the progress of regenerative medicine, mesenchymal stem cells (MSCs) have received attention as a way to restore ovarian function. It has been reported that MSCs derived from bone marrow, adipose, umbilical cord blood, menstrual blood, and amniotic fluid improved ovarian function. In light of previous studies and advances in this field, there are increased expectations regarding the utilization of MSCs to restore ovarian function. This review summarizes recent research into potential applications of MSCs in women with infertility or primary ovarian insufficiency, including cases where these conditions are induced by anticancer therapy.
format Online
Article
Text
id pubmed-6436469
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Korean Society for Reproductive Medicine
record_format MEDLINE/PubMed
spelling pubmed-64364692019-04-03 Mesenchymal stem cells for restoration of ovarian function Yoon, Sook Young Clin Exp Reprod Med Review With the progress of regenerative medicine, mesenchymal stem cells (MSCs) have received attention as a way to restore ovarian function. It has been reported that MSCs derived from bone marrow, adipose, umbilical cord blood, menstrual blood, and amniotic fluid improved ovarian function. In light of previous studies and advances in this field, there are increased expectations regarding the utilization of MSCs to restore ovarian function. This review summarizes recent research into potential applications of MSCs in women with infertility or primary ovarian insufficiency, including cases where these conditions are induced by anticancer therapy. Korean Society for Reproductive Medicine 2019-03 2019-03-01 /pmc/articles/PMC6436469/ /pubmed/30827071 http://dx.doi.org/10.5653/cerm.2019.46.1.1 Text en Copyright © 2019. THE KOREAN SOCIETY FOR REPRODUCTIVE MEDICINE This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Yoon, Sook Young
Mesenchymal stem cells for restoration of ovarian function
title Mesenchymal stem cells for restoration of ovarian function
title_full Mesenchymal stem cells for restoration of ovarian function
title_fullStr Mesenchymal stem cells for restoration of ovarian function
title_full_unstemmed Mesenchymal stem cells for restoration of ovarian function
title_short Mesenchymal stem cells for restoration of ovarian function
title_sort mesenchymal stem cells for restoration of ovarian function
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436469/
https://www.ncbi.nlm.nih.gov/pubmed/30827071
http://dx.doi.org/10.5653/cerm.2019.46.1.1
work_keys_str_mv AT yoonsookyoung mesenchymalstemcellsforrestorationofovarianfunction